Home Forums General Medicine EBOLA VIRUS- AN UPDATE-‘ W H O’- WORLD ALERT

This topic contains 1 voice and has 0 replies.
1 voice
0 replies
  • Author
  • #2320

    A medical alert has been issued in UK, re: Ebola Virus disease affecting humans in West Africa. There have been 720 deaths to date in West Africa. Air travel has increased the need for extreme care in the risk of the disease being carried into countries.- WORLD HEALTH ORGANISATION ALERT.

    Ebola virus disease

    Key facts
    Ebola virus disease (EVD), formerly known as Ebola haemorrhagic fever, is a severe, often fatal illness in humans.
    EVD outbreaks have a case fatality rate of up to 90%.
    EVD outbreaks occur primarily in remote villages in Central and West Africa, near tropical rainforests.
    The virus is transmitted to people from wild animals and spreads in the human population through human-to-human transmission.
    Fruit bats of the Pteropodidae family are considered to be the natural host of the Ebola virus.
    Severely ill patients require intensive supportive care. No licensed specific treatment or vaccine is available for use in people or animals.


    Ebola is introduced into the human population through close contact with the blood, secretions, organs or other bodily fluids of infected animals. In Africa, infection has been documented through the handling of infected chimpanzees, gorillas, fruit bats, monkeys, forest antelope and porcupines found ill or dead or in the rainforest.

    Ebola then spreads in the community through human-to-human transmission, with infection resulting from direct contact (through broken skin or mucous membranes) with the blood, secretions, organs or other bodily fluids of infected people, and indirect contact with environments contaminated with such fluids.

    Burial ceremonies in which mourners have direct contact with the body of the deceased person can also play a role in the transmission of Ebola.
    Men who have recovered from the disease can still transmit the virus through their semen for up to 7 weeks after recovery from illness.

    Health-care workers have frequently been infected while treating patients with suspected or confirmed EVD. This has occurred through close contact with patients when infection control precautions are not strictly practiced.

    Signs and symptoms
    EVD is a severe acute viral illness often characterized by the sudden onset of fever, intense weakness, muscle pain, headache and sore throat.
    This is followed by vomiting, diarrhoea, rash, impaired kidney and liver function, and in some cases, both internal and external bleeding.

    Laboratory findings include low white blood cell and platelet counts and elevated liver enzymes.
    People are infectious as long as their blood and secretions contain the virus. Ebola virus was isolated from semen 61 days after onset of illness in a man who was infected in a laboratory.

    The incubation period, that is, the time interval from infection with the virus to onset of symptoms, is 2 to 21 days.


    Other diseases that should be ruled out before a diagnosis of EVD can be made include: malaria, typhoid fever, shigellosis, cholera, leptospirosis, plague, rickettsiosis, relapsing fever, meningitis, hepatitis and other viral haemorrhagic fevers.

    Ebola virus infections can be diagnosed definitively in a laboratory through several types of tests:
    antibody-capture enzyme-linked immunosorbent assay (ELISA)
    antigen detection tests
    serum neutralization test
    reverse transcriptase polymerase chain reaction (RT-PCR) assay
    electron microscopy
    virus isolation by cell culture.

    Samples from patients are an extreme biohazard risk; testing should be conducted under maximum biological containment conditions.

    Vaccine and treatment
    No licensed vaccine for EVD is available. Several vaccines are being tested, but none are available for clinical use.

    Severely ill patients require intensive supportive care. Patients are frequently dehydrated and require oral rehydration with solutions containing electrolytes or intravenous fluids.
    No specific treatment is available. New drug therapies are being evaluated.

    G Mohan

You must be logged in to reply to this topic.